Efficacy of LCAR-T2C CAR-T cells
BRYY-IIT-LCYJ-2021-011
Phase 1 small_molecule terminated
Quick answer
Efficacy of LCAR-T2C CAR-T cells for T Cell Lymphoma is a Phase 1 program (small_molecule) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Legend Biotech Corp
- Indication
- T Cell Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated